Literature DB >> 10833691

Use of complementary medicine by adult patients participating in cancer clinical trials.

A Sparber1, L Bauer, G Curt, D Eisenberg, T Levin, S Parks, S M Steinberg, J Wootton.   

Abstract

PURPOSE/
OBJECTIVES: To document the prevalence, demographic correlates, patterns of use, and beliefs about complementary and alternative medicine (CAM) therapies of adult patients enrolled in National Cancer Institute (NCI) clinical trials.
DESIGN: Prospective, cross-sectional, descriptive survey.
SETTING: W.G. Magnuson Clinical Center of the National Institutes of Health in Bethesda, MD. SAMPLE: Convenience sample of 100 English-speaking, adult patients with cancer admitted to intramural clinical trials.
METHODS: A standardized, 99-item questionnaire assessing use of CAM therapies pre- and postcancer diagnosis was administered by face-to-face interview. MAIN RESEARCH VARIABLES: Use of CAM therapies, beliefs, communication with physician.
FINDINGS: 63% used at least one CAM therapy, with an average use of two therapies per patient. Men were significantly less likely to use a therapy than women; women were more likely to use numerous therapies. Cancer diagnosis seems to have had no influence overall on the frequency of use of CAM therapies. The major reasons stated for CAM use were for treatment-related medical conditions as well as depression, anxiety, and insomnia. The most frequently reported therapies were spiritual, relaxation, imagery, exercise, lifestyle diet (e.g., macrobiotic, vegetarian), and nutritional supplementation. Patients unanimously believed that these complementary therapies helped to improve their quality of life through more effective coping with stress, decreasing the discomforts of treatment and illness, and giving them a sense of control.
CONCLUSIONS: Patients with cancer use various complementary therapies to cope with their disease and the rigors of clinical trials. Women and those with higher educational backgrounds were more frequent users. IMPLICATIONS FOR NURSING PRACTICE: Nurses who provide care to subjects of biomedical research have an opportunity and responsibility regarding their patients' use of CAM therapies. Nurses may use in-house resources to help evaluate subjects' use of a CAM modality or to provide quality-of-life therapies such as relaxation, imagery, or healing touch. Discussing these health practices in a nonjudgmental manner adds to the assessment of patients' coping skills and ability to make decisions about their health care.

Entities:  

Mesh:

Year:  2000        PMID: 10833691

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  49 in total

1.  Complementary and alternative medicine use among men with prostate cancer in 4 ethnic populations.

Authors:  Marion M Lee; Jeffrey S Chang; Bradly Jacobs; Margaret R Wrensch
Journal:  Am J Public Health       Date:  2002-10       Impact factor: 9.308

Review 2.  Polypharmacy in older adults with cancer.

Authors:  Ronald J Maggiore; Cary P Gross; Arti Hurria
Journal:  Oncologist       Date:  2010-04-24

3.  Preservation of immune function in cervical cancer patients during chemoradiation using a novel integrative approach.

Authors:  Susan K Lutgendorf; Elizabeth Mullen-Houser; Daniel Russell; Koen Degeest; Geraldine Jacobson; Laura Hart; David Bender; Barrie Anderson; Thomas E Buekers; Michael J Goodheart; Michael H Antoni; Anil K Sood; David M Lubaroff
Journal:  Brain Behav Immun       Date:  2010-06-30       Impact factor: 7.217

4.  Prevalence of complementary and alternative medicine use in cancer patients during treatment.

Authors:  Jennifer S Yates; Karen M Mustian; Gary R Morrow; Leslie J Gillies; Devi Padmanaban; James N Atkins; Brian Issell; Jeffrey J Kirshner; Lauren K Colman
Journal:  Support Care Cancer       Date:  2005-02-15       Impact factor: 3.603

5.  Prostate tumor growth can be modulated by dietarily targeting the 15-lipoxygenase-1 and cyclooxygenase-2 enzymes.

Authors:  Uddhav P Kelavkar; Justin Hutzley; Kevin McHugh; Kenneth G D Allen; Anil Parwani
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

6.  Use of complementary and alternative medicine by cancer patients at Zhejiang University Teaching Hospital Zhuji Hospital, China.

Authors:  Lisong Teng; Ketao Jin; Kuifeng He; Chunge Bian; Weili Chen; Kaiyan Fu; Tieming Zhu; Zhigang Jin
Journal:  Afr J Tradit Complement Altern Med       Date:  2010-07-03

7.  Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center.

Authors:  T Zeller; K Muenstedt; C Stoll; J Schweder; B Senf; E Ruckhaeberle; S Becker; H Serve; J Huebner
Journal:  J Cancer Res Clin Oncol       Date:  2012-10-26       Impact factor: 4.553

8.  Propolis and its Active Component, Caffeic Acid Phenethyl Ester (CAPE), Modulate Breast Cancer Therapeutic Targets via an Epigenetically Mediated Mechanism of Action.

Authors:  Coral Omene; Matko Kalac; Jing Wu; Enrica Marchi; Krystyna Frenkel; Owen A O'Connor
Journal:  J Cancer Sci Ther       Date:  2013-10-21

9.  The prevalence and correlates of mind-body therapy practices in patients with acute coronary syndrome.

Authors:  Yvonne W Leung; Hala Tamim; Donna E Stewart; Heather M Arthur; Sherry L Grace
Journal:  Complement Ther Med       Date:  2008-10       Impact factor: 2.446

10.  Trick or treat? Australian newspaper portrayal of complementary and alternative medicine for the treatment of cancer.

Authors:  Reegan Mercurio; Jaklin Ardath Eliott
Journal:  Support Care Cancer       Date:  2009-11-27       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.